Volume 13, Issue 1 (1-2015)                   IJRM 2015, 13(1): 27-34 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hasan Hashim Z, Bader Hamdan F, Rashid Al-Salihi A. Autonomic dysfunction in women with polycystic ovary syndrome. IJRM 2015; 13 (1) :27-34
URL: http://ijrm.ir/article-1-588-en.html
1- Department of Physiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq
2- Department of Physiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq , farqadbhamdan@colmed-alnahrain.edu.iq
3- The High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq
Abstract:   (2595 Views)
Background: Central obesity and hyperinsulinaemia of polycystic ovary syndrome (PCOS) are associated with chronic sympathetic over activity.
Objective: To evaluate the autonomic functions and to indicate the superiority, if any, for those functions in the diagnosis of sympathetic over activity in PCOS women.
Materials and Methods: Sixty-four PCOS patients and 40 women served as the control group were studied. The two groups were subdivided according to the body mass index (BMI) into two obese and non-obese groups. Waist:hip ratio (WHR), plasma epinephrine level was estimated, sympathetic skin response (SSR); postural orthostatic tachycardia syndrome, heart rate variability (HRV), and valsalva ratio were measured in both groups.
Results: Compared to the control group, obese PCOS patients demonstrated higher BMI and WHR, reduced palmar SSR latency and higher amplitude, altered HRV, higher plasma epinephrine level, and rapid pulse rate. Moreover, non-obese patients show reduced palmar SSR latency and higher amplitude, higher plasma epinephrine level, and higher pulse rate. BMI and WHR of the patients were positively correlated with plasma epinephrine level; while the HRV was negatively correlated WHR.
Conclusion: Women with PCOS exhibits altered autonomic function and sympathoexcitation is more pronounced in obese than non-obese patients; therefor the SSR could be useful auxiliary electrophysiological test to predict autonomic dysfunction in those patients. Receiver operating characteristics curve demonstrate the pulse rate in standing position as the autonomic function test that is superior to others in predicting sympathetic over activity in those patients.
Full-Text [PDF 212 kb]   (693 Downloads) |   |   Full-Text (HTML)  (434 Views)  
Type of Study: Original Article |

References
1. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363-2369. [DOI:10.1097/00004872-200412000-00019]
2. de Sá JC, Costa EC, da Silva E, Zuttin RS, da Silva EP, Lemos TM, et al. Analysis of heart rate variability in polycystic ovary syndrome. Gynecol Endocrinol 2011; 27: 443-447. [DOI:10.3109/09513590.2010.501881]
3. Lansdown A, Rees AD. The Sympathetic Nervous System in Polycystic Ovary Syndrome: a novel therapeutic target? Clin Endocrinol (Oxf) 2012; 77: 791-801. [DOI:10.1111/cen.12003]
4. Stener-Victorin E, Jedel E, Manneras L. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence. J Neuroendocrinol 2008; 20: 290-298. [DOI:10.1111/j.1365-2826.2007.01634.x]
5. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Autonomic tone and reflexes after myocardial infarction investigators. Lancet 2007; 351: 478-484.
6. Yildirir A, Aybar F, Kabakci G, Yarali H, Oto A. Heart rate variability in young women with polycystic ovary syndrome. Ann Noninvasive Electrocardiol 2006; 11: 306-312. [DOI:10.1111/j.1542-474X.2006.00122.x]
7. de Sá JC, Costa EC, da Silva E, Azevedo GD. Heart rate variability as a method of assessing the autonomic nervous system in polycystic ovary syndrome. Rev Bras Ginecol Obstet 2013; 35: 421-426.
8. Di Domenico K, Wiltgen D, Nickel FJ, Magalhaes JA, Moraes RS, Spritzer PM. Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter? Fertil Steril 2013; 99: 286-292. [DOI:10.1016/j.fertnstert.2012.08.049]
9. Novak P. Quantitative Autonomic Testing. J Vis Exp 2011; 53: 2502. [DOI:10.3791/2502]
10. Yun DJ, Choi HN, Oh G. A Case of Postural Orthostatic Tachycardia Syndrome Associated with Migraine and Fibromyalgia. Korean J Pain 2013; 26: 303-306. [DOI:10.3344/kjp.2013.26.3.303]
11. Benarroch EE. Peripheral autonomic system: Anatomy, biochemistry and physiology. In: Low PA, Benarroch EE (eds).Clinical Autonomic Disorders. 3rd Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: 29-42.
12. Barrett KE, Barman SM, Boitano S, Brooks HL. Cardiovascular regulatory mechanisms. In: Barrett KE, Barman SM, Boitano S, Brooks HL (ed.). Ganong's Review of Medical Physiology. 23rd Ed. New Delhi, Tata McGraw-Hill Companies; 2010: 555-568.
13. Kucera P, Goldenberg Z, Kurka E. Sympathetic skin response: review of the method and its clinical use. Bratisl Lek Listy 2004; 105: 108-116.
14. Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM. Estimation of truncal adiposity using waist circumference or the sum of trunk skin folds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 2007; 56: 992-997. [DOI:10.1016/j.metabol.2007.03.006]
15. Shahani BT, Halperin JJ, Boulu P, Cohen TJ. Sympathetic skin response-a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiat 1984; 47:536-542. [DOI:10.1136/jnnp.47.5.536]
16. Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH. et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 470-476. [DOI:10.1210/jc.2007-1756]
17. Ingvar EK, Arner P, Ryde´n M, Holm C, Thörne A, Hoffstedt J, et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 2002; 51: 484-492. [DOI:10.2337/diabetes.51.2.484]
18. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertension 1999; 17: 1125-1133. [DOI:10.1097/00004872-199917080-00012]
19. Raj S. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis and management. Indian Pacing Electrophysiol J 2006; 6: 84-99.
20. Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, et al. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol 2008; 1: 103-109. [DOI:10.1161/CIRCEP.107.750471]
21. Jacob G, Costa F, Shannon J, Robertson RM, Wathen M, Stein M, et al. The neuropathic postural tachycardia syndrome. N Engl J Med 2000; 343: 1008-14. [DOI:10.1056/NEJM200010053431404]
22. Goldstein DS, Holmes C, Frank SM, Dendi R, Cannon III RO, Sharabi Y, et al. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation 2002; 106: 2358-2365. [DOI:10.1161/01.CIR.0000036015.54619.B6]
23. Swift MN, Charkoudian N, Dotson RM, Suarez GA, Low PA. Baroreflex control of muscle sympathetic nerve activity in the postural orthostatic tachycardia syndrome. Am J Physiol Heart Circ Physiol 2005; 289: 1226-1233. [DOI:10.1152/ajpheart.01243.2004]
24. Raj SR. Postural Tachycardia Syndrome (POTS). Circulation 2013; 127: 2336-2342. [DOI:10.1161/CIRCULATIONAHA.112.144501]
25. Stewart JM. Pooling in chronic orthostatic intolerance. Circulation 2002; 105: 2274-2281. [DOI:10.1161/01.CIR.0000016348.55378.C4]
26. Grubb BP. Postural tachycardia syndrome. Circulation 2008; 117: 2814-2817. [DOI:10.1161/CIRCULATIONAHA.107.761643]
27. Uckuyu A, Toprak E, Ciftci O, Ciftci FC. The fluctuation in the heart rate variability throughout ovulation induction cycle: is the case different in polycystic ovary syndrome? Gynecol Obstet 2013; 3: 172-176.
28. Saranya K, Pal GK, Habeebullah S, Pal P. Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2014; 40: 192-199. [DOI:10.1111/jog.12154]
29. Sandercock GR, Bromley PD, Brodie DA. The reliability of short-term measurements of heart rate variability. Int J Cardiol 2005; 103: 238-247. [DOI:10.1016/j.ijcard.2004.09.013]
30. Lombardi F. Clinical implication of present physiology understanding of HRV components. Card Electrophysiol Rev 2002; 6: 245-249. [DOI:10.1023/A:1016329008921]
31. Stein PK. Assessing heart rate variability from real-world Holter reports. Card Electrophysiol Rev 2002; 6: 239-44. [DOI:10.1023/A:1016376924850]
32. Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984; 7: 447-453. [DOI:10.2337/diacare.7.5.447]
33. Lyu RK, Tang LM, Hsu WC, Chen ST. Quantitative cardiovascular autonomic function study in Fisher syndrome. J Neurol Neurosurg Psychiat 2002; 73: 333-335. [DOI:10.1136/jnnp.73.3.333]
34. Bidzinska-Speichert B. Treatment of PCOS. Endocrine Abs 2008; 16: S16.
35. Kim SS, Rosenfield RL. Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl. Arch Dermatol 2000; 136: 430-431. [DOI:10.1001/archderm.136.3.430]
36. Rubinsztajn R, Kumor M, Byskiniewicz K, Chazan R. the sympathetic activity and its correlation with body mass index (BMI) in patients with obstructive sleep apnea (OSA). Chest 2003; 124: 74S. [DOI:10.1378/chest.124.4_MeetingAbstracts.74S-a]
37. Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, et al. Overweight and sympathetic overactivity in black Americans. Hypertension 2001; 38: 379-383. [DOI:10.1161/01.HYP.38.3.379]
38. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007; 25: 1411-1419. [DOI:10.1097/HJH.0b013e3281053af4]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb